Mitsuhiko Osaki

No ORCID on file · 5 papers in corpus · active 2015-2024

Study types

  • article 3
  • other 2

Condition tags

  • endometriosis 3
  • adenomyosis 2
  • endometrioma 1
other 2024
Corrigendum to "Increased chemokine ligand 26 expression and its involvement in epithelial-mesenchymal transition in the endometrium with adenomyosis" [Volume 52, Issue 9 (2023) 102645]
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2024.102741
article 2023
Increased chemokine ligand 26 expression and its involvement in epithelial-mesenchymal transition in the endometrium with adenomyosis
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2023.102645
article 2018
New insights into the efficacy of SR‐16234, a selective estrogen receptor modulator, on the growth of murine endometriosis‐like lesions
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.13023

PROBLEM: To evaluate the effects of SR-16234 (SR), a selective estrogen receptor modulator (SERM), on murine endometriosis-like lesions. METHOD OF STUDY: BALB/c mice (n = 53) were used to establish the murine endometriosis model. Ovariectom…

article 2016
treating endometriosis
other 2015
Inhibitor of apoptosis proteins (IAPs) may be effective therapeutic targets for treating endometriosis
Human Reproduction ·doi:10.1093/humrep/deu288

STUDY QUESTION: What is the role of the inhibitor of apoptosis proteins (IAPs) in human endometriotic tissues and a mouse model of endometriosis? SUMMARY ANSWER: Four IAP proteins were expressed in endometriotic tissue indicating IAPs may …